Call 08048618313 88% Response Rate

Send Enquiry

our range

Api Intermediate

We are a leading Wholesale Trader of sitagliptin phosphate api, olumiant baricitinib 4mg, febuxostat api intermediate and medicine grade ticagrelor api from Vadodara, India.

Sitagliptin Phosphate Api

Sitagliptin Phosphate Api
Get Best Quote
Price on Request
Grade StandardIP
PurityGreater than 99%
CompositionApi sitagliptin
Packaging TypeBox
Chemical FormulaC16H15F6N5O
Molecular Weight523.32 grams/mole
Treatmentused to treat type 2 diabetes in adults
Sitagliptin Phosphate Monohydrate, known under the Brand Name of Janumet & Janumet XR is an anti-diabetic medication developed by Merck & Co used to treat type 2 diabetes.We are manufacturer, exporter & marketer of world class quality branded generic & generic medicine

View Complete details

Yes! I am Interested Request a call back

Olumiant Baricitinib 4mg

  • Olumiant Baricitinib 4mg
  • Olumiant Baricitinib 4mg
Olumiant Baricitinib 4mg
Get Best Quote
Rs 7,000  / BoxPrice on Request
Strength / Dose4 mg
Packaging TypeStrip
Packaging Size7 Tablets
BrandOlumiant
ManufacturerLilly

View Complete details

Yes! I am Interested Request a call back

Febuxostat Api Intermediate

Febuxostat Api Intermediate
Get Best Quote
Rs 100  / KgPrice on Request
GradePharma Grade
Packaging25Kg Bag
Purity90%-95%
Packaging TypeBag
Molecular Weight316.4 g/mol
Chemical FormulaC16H16N2O3S
TreatmentUsed to treat gout and hyperuricemia, or high levels of uric acid in the blood
Febuxostat is a xanthine oxidase inhibitor used for the management of chronic hyperuricemia in adults with gout who have an inadequate response or intolerance to allopurinol. Febuxostat is a non-purine xanthine oxidase (XO) inhibitor. 

View Complete details

Yes! I am Interested Request a call back

Medicine Grade Ticagrelor Api

Medicine Grade Ticagrelor Api
Get Best Quote
Rs 55,000  / KgPrice on Request
Dose/Strength90 mg
Purity99%
Molecular Weight522.57
Shelf Life2 years
TreatmentPrevents Heart Attack
Pack Size1kg
Ticagrelor is indicated to reduce the risk of cardiovascular death, myocardial infarction, and stroke in patients with acute coronary syndrome or a history of myocardial infarction.

View Complete details

Yes! I am Interested Request a call back

EXPLORE MORE CATEGORIES